Product How it works Pricing Blog FAQ About Contact
Innoviva

Innoviva (NASDAQ: INVA) revenue

Innoviva reported revenue of $411.3m for fiscal 2025, 14.7% more than in fiscal 2024 ($358.7m). Since fiscal 2016 its revenue has grown by 208.0%, an average growth of 13.3% a year.

Innoviva has grown its revenue for 2 years in a row, and fiscal 2025 is the highest of its 10 fiscal years on record. The biggest drop was in fiscal 2022, −15.4%.

Revenue, in millions of US dollars133.62016217.22017261.02018261.02019336.82020391.92021331.32022310.52023358.72024411.32025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$411.3m+14.7%$163.7m39.8%
2024$358.7m+15.5%$166.9m46.5%
2023$310.5m−6.3%$113.9m36.7%
2022$331.3m−15.4%$302.7m91.4%
2021$391.9m+16.4%$375.1m95.7%
2020$336.8m+29.0%$321.1m95.3%
2019$261.0m0.0%$246.4m94.4%
2018$261.0m+20.2%$238.3m91.3%
2017$217.2m+62.6%$183.6m84.5%
2016$133.6m—$109.0m81.6%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Innoviva revenue compared with its sector

By revenue for its latest fiscal year, Innoviva ranks 203rd of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Innoviva, 14.7%.

RankCompanyRevenueRevenue growth
201stCertara$418.8m8.7%
202ndMiMedx Group$418.6m20.0%
203rdInnoviva$411.3m14.7%
204thArdelyx$407.3m22.1%
205thImmunocore$400.0m29.0%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Innoviva

How much revenue did Innoviva make in fiscal 2025?
Innoviva reported revenue of $411.3m for fiscal 2025, compared with $358.7m in fiscal 2024.
How much has the revenue of Innoviva grown?
Between fiscal 2016 and fiscal 2025 it went from $133.6m to $411.3m: 208.0% more, an average growth of 13.3% a year.
What was the best year for revenue at Innoviva?
Of its last 10 fiscal years, fiscal 2025, with $411.3m.
Where does Innoviva rank in its sector by revenue?
It ranks 203rd of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Innoviva come from?
From the annual report (Form 10-K) that Innoviva files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Innoviva files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Innoviva: the Innoviva page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.